2007-March Archives by Thread

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...

Starting: Thu Mar 1 05:09:23 2007
Ending: Sat Mar 31 19:44:29 2007
Messages: 198

• [Ip-health] Mashelkar Plagiarism Controversy-2   Lawrence Liang
• [Ip-health] Bridges Weekly: BREAKTHROUGH ON WIPO DEVELOPMENT AGENDA   Thiru Balasubramaniam
• [Ip-health] Bangladesh submission to WHO IGWG on Public Health, Innovation and Intellectual Property Rights   James Packard Love
• [Ip-health] Caution over Swiss Firm Patenting Cancer-fighting Drug   Joana Ramos
• [Ip-health] Submission to WHO/IGWG by Bolivia, in Spanish   James Packard Love
• [Ip-health] English translation: Submission to WHO/IGWG by Bolivia   James Packard Love
• [Ip-health] Email alert: March issue of the WHO Bulletin   bulletin
• [Ip-health] Brazil submission to WHO/IGWG   James Packard Love
• [Ip-health] FDA warns drugmakers over unapproved headache drugs   Joana Ramos
• [Ip-health] MSF study on second-line AIDS treatment in resource poor settings: But Access to newer medicines remains an alarming proglem   Buddhima Lokuge
• [Ip-health] Launch of new non-patented Low-Cost Antimalaria medicine   Buddhima Lokuge
• [Ip-health] =?Windows-1252?Q?Mint_India:_There=92s_a_lesson_to_be_learnt_here=2C_says?= =?Windows-1252?Q?_Mashelkar?=   Achal Prabhala
• [Ip-health] IPN et. al.: UN, =?windows-1252?Q?governments=92_policies_ca?= =?windows-1252?Q?use_avoidable_disease_and_suffering?=   robert weissman
• [Ip-health] Changes in US patent review process   Rohit Malpani
• [Ip-health] Novartis letter to the MEPs requesting them to not sign the Written Declaration. In the Declaration MEPs call Novartis to withdraw the case and call the EU Commission and EU Council to take a similar position   Alexandra HEUMBER
• [Ip-health] Compulsory Licences could save 1Bln baht   Sarah Rimmington
• [Ip-health] (no subject)   chan park
• [Ip-health] possible legislation to raise standards for US patents   Benjamin Krohmal
• [Ip-health] Dates for June WIPO PCDA and SCCR meetings   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Global Health, China's Pride On Line in Malaria Clash   Thiru Balasubramaniam
• [Ip-health] Novartis Hearing Update, 6.3.07   chan park
• [Ip-health] Concern about benefits of RED aids campaign   Michelle Childs
• [Ip-health] Vasella questioned at the General Meeting in Basel about Novartislegal action against India   Alexandra HEUMBER
• [Ip-health] Washington Times Op-ed: The Innovation Agenda   Sarah Rimmington
• [Ip-health] Compulsory licensing of patents: Communique issued by the French Minister for Research, Paris 07.09.2001   James Packard Love
• [Ip-health] KEI Brown Bag: Hanson on Grants vs. Prizes for Innovation   Benjamin Krohmal
• [Ip-health] Glivec raises concerns on post-marketing study (factiva)]   Joana Ramos
• [Ip-health] Celgene, Novartis File Suit to Block Generic Ritalin   Joana Ramos
• [Ip-health] Combivir patent rejected in China   James ARKINSTALL
• [Ip-health] Wall Street Journal Editorial: Bangkok's Drug War Goes Global   Thiru Balasubramaniam
  • [Ip-health] Wall Street Journal Editorial: Bangkok's Drug War Goes Global   James Packard Love
    • [Ip-health] Wall Street Journal Editorial: Bangkok's Drug War Goes Global   Jeff Williams
• [Ip-health] Novartis Image Shaken with GIPAP Scandal   Joana Ramos
• [Ip-health] Wall Street Journal: Novartis Angers Critics in India   Thiru Balasubramaniam
• [Ip-health] [Fwd: [NHeLP] Job Opening: Staff Attorney at PAL   Joana Ramos
• [Ip-health] The Hindu: Dilip Shah of IPA on Mashelkar Report   chan park
• [Ip-health] George Washington University's CIEC's "Partners"   James Packard Love
• [Ip-health] Lisa Conte in Huffington Post on Novartis Case   Mike Palmedo
• [Ip-health] Bridges Weekly: BANGLADESH AND BOLIVIA CALL FOR EXTENSION OF WHO WORKING GROUP ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY   Thiru Balasubramaniam
• [Ip-health] Glivec Controversy : Spanner In The Works   Joana Ramos
• [Ip-health] Novartis's Rebuttal: Glivec Controversy: Spanner In The Works   Joana Ramos
• [Ip-health] IP-Watch (Monthly Edition): WIPO Development Agenda Negotiation Surges Ahead   Thiru Balasubramaniam
• [Ip-health] Times of India Editorial, Generic drugs only hope for many AIDS, Cancer Patients   msfh-india-medco-assist
• [Ip-health] patent save lifes - Brazilian Directof of corporate Affairs of Novartis in the Gazeta Mercatil - Brazil   MSF Michel Lotrowska
• [Ip-health] Richard Rockefeller, Times of India Editorial published today   Alexandra HEUMBER
• [Ip-health] Merck's Murky Dealings: HPV Vaccine Lobby Backfires   Riaz K Tayob
• [Ip-health] Mashelkar committee report   Graham Dutfield
• [Ip-health] Pepfar, Generics, Price   robert weissman
• [Ip-health] Stiglitz on medical innovation prizes   Benjamin Krohmal
• [Ip-health] Manufacturing costs for second line AIDS drugs   James Packard Love
• [Ip-health] PROMINENT INNOVATION PRIZES AND REWARD PROGRAMS   James Packard Love
• [Ip-health] Thailand, Wall Street Journal and Media Prostitution   Daya Shanker
• [Ip-health] [UAEM] Universities Release Best Practices for Licensing "In the Public Interest"   Robynn Sturm
• [Ip-health] Who is SIGWatch and where does it get its info on patents cases?   Joana Ramos
• [Ip-health] Recent examples of the use of compulsory licenses on patents   James Packard Love
• [Ip-health] The economist on Prizes for Innovation   Ellen 't Hoen
• [Ip-health] About Mr Myc Riggulsford   James Packard Love
• [Ip-health] Statement in the British Parliament on Thailand CL   James Packard Love
• [Ip-health] $250,000 Open Architecture Prize prize for developing world.   James Love
• [Ip-health] REMINDER: KEI Brown Bag this Friday   Benjamin Krohmal
• [Ip-health] KEI Brownbag this Thursday: Sakiko Fukuda-Parr on The Gene Revolution   Malini Aisola
• [Ip-health] Letter from 12 U.S. Congress members to USTR Representative Susan Schwab: US Trade Policies Restrict Access to Life Saving Medicines   Thiru Balasubramaniam
• [Ip-health] Ronald A. Cass in the Wall Street Journal: Thai Patent Turmoil   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Thailand Presents Report On Compulsory Licensing Experience   Mike Palmedo
• [Ip-health] Abbott won't launch new drugs in Thailand   Benjamin Krohmal
• [Ip-health] Frontline: Cleaning up after Mashelkar - Praful Bidwai   Achal Prabhala
• [Ip-health] Frontline: Batting for MNCs - Dinesh Abrol   Achal Prabhala
• [Ip-health] Frontline: Against Monopoly - Yusuf Hamied   Achal Prabhala
• [Ip-health] ZeeNews: Mashelkar can resubmit report - Govt   Achal Prabhala
• [Ip-health] Highlights from the European Union's 17 May 2007 regulation on compulsory licensing   James Packard Love
  • [Ip-health] Highlights from the European Union's 17 May 2007 regulation on compulsory licensing   James Packard Love
• [Ip-health] Re: [aidsdrugs] Abbott Abusive Registration Practices   B.Baker@neu.edu
  • [Ip-health] Re: [aidsdrugs] Abbott Abusive Registration Practices   James Packard Love
• [Ip-health] Colombian study on impact of FTA on medicines   Mike Palmedo
• [Ip-health] WSJ: "Why Generic Doesn't Always Mean Cheap"   Benjamin Krohmal
• [Ip-health] Letters to Wall Street Journal from KEI, IFPMA and Oxfam on "Bangkok's Drug War Goes Global" editorial   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal editorial: The Thai Flu   Thiru Balasubramaniam
• [Ip-health] MSF's response to WSJ Editorial on March 7, 2007   Buddhima Lokuge
• [Ip-health] Abbott excessive pricing of AIDS drug investigation likely in US   Buddhima Lokuge
• [Ip-health] PIJIP Analysis of Thai Law on Government Use Licenses   Mike Palmedo
• [Ip-health] "Mandelson keeps mum on Indian drugs case"   Alexandra HEUMBER
• [Ip-health] Friday Capitol Hill Briefing on Thailand Situation   Benjamin Krohmal
• [Ip-health] Thailand briefing details   Benjamin Krohmal
• [Ip-health] Business Standard: Mashelkar gets time to purge `follies`   Achal Prabhala
• [Ip-health] The Hindu: Expert group to review Mashelkar report   Achal Prabhala
• [Ip-health] comments from Abbott, Thailand   Benjamin Krohmal
• [Ip-health] March 8, 2007 Geneva Q&A Session on Thai White Paper   James Packard Love
• [Ip-health] Le Temps (Swiss newspaper): Abbott ne laisse pas intimider en Thailande   Thiru Balasubramaniam
• [Ip-health] Bridges Weekly: AGREEMENT ELUDES US AND KOREA IN FTA TALKS, DESPITE PROGRESS   Thiru Balasubramaniam
• [Ip-health] Bridges Weekly: THAI GOVERNMENT EXPLAINS COMPULSORY LICENCE POLICY ON PATENTED DRUGS   Thiru Balasubramaniam
• [Ip-health] REMINDER: KEI Brownbag TODAY on The Gene Revolution   Malini Aisola
• [Ip-health] Abbott - A New Low in the Pharma Drug Wars   B.Baker@neu.edu
  • [Ip-health] Re: [e-drug] Abbott Withdraws Seven Medicines in Thailand   Mira Shiva
• [Ip-health] Legal Analysis of Patent Breaking/Compulsory Licensing in the Face of Public Health Crisis   Chris Nidel
• [Ip-health] MSF Denounces Abbott's Move to Withhold Medicines From People in Thailand   Benjamin Krohmal
• [Ip-health] Bayer supports Abbott's move in Thailand   Benjamin Krohmal
• [Ip-health] France - GSK found guilty of predatory pricing to hinder generic entry   James Love
• [Ip-health] Times of India: Interest Group Capture - Sudhir Krishnaswamy   Achal Prabhala
• [Ip-health] The Hindu: Time for international action on patents   Achal Prabhala
• [Ip-health] Thailand's government use licences   Peter Drahos
• [Ip-health] Times of India: Mashelkar panel member in favour of fresh 'conclusions'   Achal Prabhala
• [Ip-health] TRIPS, Mashelkar and Administrative Perversion   Daya Shanker
• [Ip-health] EPW: Is Plagiarism the only problem with the Mashelkar report?   Achal Prabhala
• [Ip-health] SciDev.Net editorial: time for action on patents   James ARKINSTALL
• [Ip-health] US Commerce Secty Gutierrez Criticizes Thai CL   robert weissman
  • [Ip-health] Kenya: Pfizer launches first-ever challenge at the IP Tribunal   Christa Cepuch
• [Ip-health] The Hindu: Mashelkar quits patents expert panel   chan park
• [Ip-health] INTELLECTUAL PROPERTY AND ACCESS TO TREATMENT: HOW CAN PATENT LAW WORK FOR PUBLIC HEALTH?   Caroline Gallant
• [Ip-health] Pre G8 UK Parliament Event with Hilary Benn and Day of Action 20th March   Michelle Childs
• [Ip-health] Mashelkar resigns   kannamma raman
• [Ip-health] LA Times: Setting a Price for Putting Off Death   Mike Palmedo
• [Ip-health] US law on govt. use of patents   Benjamin Krohmal
• [Ip-health] US Supreme Court may hear pharma antitrust case   Benjamin Krohmal
• [Ip-health] Hindu interviews on Novartis Case   Ragavan, Srividhya
• [Ip-health] The Hill: House Democrats scrutinize price tag of AIDS drug   Mike Palmedo
• [Ip-health] Setting a price for putting off death: A few more months of life may not be worth the costs of new cancer therapies, some argue.   James Love
• [Ip-health] For Alexion, Third Time's The Charm...new drug, Soliris, to treat a rare blood disorder called paroxysmal nocturnal hemoglobinuria (PNH).   Joana Ramos
• [Ip-health] Activists push for global boycott   Kannikar KIJTIWATCHAKUL
• [Ip-health] [Fwd: Litigation & Enforement in the Biotech and Pharmaceutical Industry Conference - One Month Left to Register]   Joana Ramos
• [Ip-health] AP: Thai Health Groups Urge Abbott Boycott   Thiru Balasubramaniam
• [Ip-health] Reuters: Thailand Talking with Drug Firms - U.S. Chamber   Thiru Balasubramaniam
• [Ip-health] IPS: US Pharma Giant Faces Public Boycott   Thiru Balasubramaniam
• [Ip-health] Mike's notes on Korea meeting   Sean Flynn
• [Ip-health] PhRMA testimony at House Ways and Means Subcommittee on Trade   Mike Palmedo
• [Ip-health] Doctors' Ties to Drug Makers Are Put on Close View   James Packard Love
• [Ip-health] Compulsory licensing of patents under ebay decision   James Packard Love
• [Ip-health] University of Arkansas immunity from patent infringment   James Packard Love
• [Ip-health] Compulsory licensing of patents under ebay decision   Luis Villarroel Villalon
  • [Ip-health] Compulsory licensing of patents under ebay decision   James Packard Love
• [Ip-health] Petition: support public access to medical research   Benjamin Krohmal
• [Ip-health] Compulsory licensing of patents under ebay decision   Anne St. Martin
  • [Ip-health] Compulsory licensing of patents under ebay decision   michael.davis@law.csuohio.edu
    • [Ip-health] Compulsory licensing of patents under ebay decision   Amy Kapczynski
• [Ip-health] Korea hearing and health: Rep. Blumenauer's tobacco questions, pharma   Ellen Shaffer
• [Ip-health] State impacts of Korea FTA   Sean Flynn
• [Ip-health] US Chamber of Commerce on Thailand's IP   Mike Palmedo
• [Ip-health] TNA: EC "concerned" over Thai CLs   Khalil Elouardighi - Act Up-Paris
• [Ip-health] 'All costs, no benefits: How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines'.   Elizabeth Wabuge
• [Ip-health] 2007 Accelerating Anticancer Agent Development and Validation Workshop   Joana Ramos
• [Ip-health] New Oxfam briefing paper on the costs and benefits of the US - Jordan free trade agreement   Rohit Malpani
• [Ip-health] Editorial: Putting meaning back into TRIPS   Sarah Rimmington
• [Ip-health] Who will be sued next? - Scrip editorial   Ellen T HOEN
• [Ip-health] Indian Express: Terra pharma   Achal Prabhala
• [Ip-health] Amazon promotes essential facilities, reasonable royalty rules   robert weissman
  • [Ip-health] Amazon promotes essential facilities, reasonable royalty rules   Amy Kapczynski
• [Ip-health] Empirical Paper on ARVs in Sub-Saharan Africa   Colleen Chien
• [Ip-health] Investors criticize Abbott   Benjamin Krohmal
• [Ip-health] Notes from D.C. Thailand Breifing   ben.krohmal@keionline.org
• [Ip-health] Congress Leaders to USTR: Drop TRIPS-Plus in FTAs   Ellen Shaffer
• [Ip-health] Lancet: WHO and Abbott in Thailand   Kannikar KIJTIWATCHAKUL
• [Ip-health] U.S. Pres. candidate on Thailand & global framework   Benjamin Krohmal
• [Ip-health] Abbott's anticompetitive practices in Thailand   Sean Flynn
• [Ip-health] MSF. Abbott should reconsider its unacceptable decision   Buddhima Lokuge
• [Ip-health] Drug firms' funding of advocates often escapes government scrutiny   Joana Ramos
• [Ip-health] Abbott criticized; silent on Thailand   ben.krohmal@keionline.org
• [Ip-health] Economic Times: DIPP Opposes Mashelkar Suggestions   chan park
• [Ip-health] A US court judgment that is relevant to Novartis case   Joana Ramos
  • [Ip-health] A US court judgment that is relevant to Novartis case   chan park
    • [Ip-health] A US court judgment that is relevant to Novartis case   Benjamin Krohmal
  • [Ip-health] A US court judgment that is relevant to Novartis case   Jeff Williams
• [Ip-health] Fwd: [A2k] massive attack on Brazil's IPR policies   Michelle Childs
• [Ip-health] SUNS: Drug-resistant TB treatment barely succeeds   Sangeeta
  • [Ip-health] Tuberculosis. Forgotten, but not gone: from the economist   Rosa Castro
• [Ip-health] Novartis Update, 26.3.07   chan park
• [Ip-health] The Big Idea: Prizes to Stimulate R&D for New Medicines   James Packard Love
• [Ip-health] Wall Street journal: Poor Countries Seek Pact On Avian-Flu Vaccines   Thiru Balasubramaniam
• [Ip-health] PUBPAT News: PUBPAT Takes On Key HIV/AIDS Drug Patents   Public Patent Foundation
• [Ip-health] Dean Baker: Thailand takes the lead in promoting free trade   Dan Beeton
• [Ip-health] France gives public support to Thai CLs   Khalil Elouardighi - Act Up-Paris
• [Ip-health] Wall Street Journal: Democrats' New Trade Agenda May Stall Broader Bush Goals   Thiru Balasubramaniam
• [Ip-health] Italy issues compulsory license on Merck drug   James Packard Love
• [Ip-health] Novartis Update, 27.3.07   chan park
• [Ip-health] Wall Street Journal: Indonesia to Resume Sharing Bird-Flu Virus Samples   Thiru Balasubramaniam
• [Ip-health] Sanofi trying a deal in Thailand   Judit Rius Sanjuan
• [Ip-health] Ways & Means statement   Ellen Shaffer
• [Ip-health] Shamnad Basheer on India's New Patent Regime   Sean Flynn
• [Ip-health] now online - Ways & Means statement   Ellen Shaffer
• [Ip-health] Novartis Update, 28.3.07   chan park
• [Ip-health] LeMonde on Thai CL, France, Abbott   Khalil Elouardighi - Act Up-Paris
• [Ip-health] compulsory license boosts Abbott profits   Benjamin Krohmal
• [Ip-health] Philippines: U.S. Norvasc ruling supports IP reform   Benjamin Krohmal
• [Ip-health] Nature: Plagiarised report on patent laws shames Indian scientists   Achal Prabhala
• [Ip-health] Novartis Update, 29.03.07   chan park
• [Ip-health] Thailand/New business model for innovation and Thai Govt/Pharma talks   Sarah Rimmington
• [Ip-health] Democratic Urged USTR to Change Course in US-Korea FTA Negotiations   heeseob nam
• [Ip-health] Financial Times: Corners are cut in order to bring drugs to Africa   Thiru Balasubramaniam
• [Ip-health] Novartis Update, 30.03.07   chan park
• [Ip-health] Washington Post Editorial: A Dose of Innovation   Thiru Balasubramaniam
• [Ip-health] A Drug Deal Gone Bad - by Sean Flynn and Sharon Treat in Tompaine.com   Mike Palmedo
• [Ip-health] More on the Italian compulsory license for finasteride   James Packard Love
• [Ip-health] VBB on Merck Italian CL   James Packard Love
• [Ip-health] Fwd:: 60 Minutes Takes on the Drug Industry: Sunday, April 1st (No Joke)]   Joana Ramos
• [Ip-health] Georges and Bay on "the Italian Case"   James Packard Love
• [Ip-health] Two other Italian CLs, GSK's migraine drug, and Merck's broad spectrum antibiotic   James Packard Love
• [Ip-health] It: official press release on finasteride CL, (also mentions the two previous CL cases)   James Packard Love
• [Ip-health] Reuters: Korea FTA Talks Stumble at Last Minute   Mike Palmedo
• [Ip-health] Fwd: [G & H] CPATH: Korea, meds, tobacco   Ellen Shaffer
• [Ip-health] Newsweek: Thailand's New Drug War   ben.krohmal@keionline.org

Last message date: Sat Mar 31 19:44:29 2007
Archived on: Sat Mar 31 19:44:30 2007

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...